CG Oncology was founded in September 2010

CG Oncology was originally founded as a California corporation on September 24, 2010 under the name Cold Genesys, Inc. On November 30, 2017, the company reincorporated as a Delaware corporation, and on March 31, 2020, the name was formally changed to CG Oncology, Inc.

400 Spectrum Center Drive

Suite 2040

Irvine, CA 92618

You can view our Board of Directors by visiting the Board of Directors section of our website.

You can view our executive leadership team by visiting the Executive Leadership section of our website.

December 31st.

Ernst & Young LLP

CG Oncology is traded on the NASDAQ Global Select Market under the symbol “CGON”.

CG Oncology went public on January 25, 2024.

Shares can be purchased through a stockbroker of your choice.

​​​​​​CG Oncology does not offer a direct stock purchase plan.

​​​​​Currently, CG Oncology does not offer a dividend or a dividend reinvestment program.


Broadridge Corporate Issuer Solutions, LLC

51 Mercedes Way

Edgewood, NY 11717

Please contact our transfer agent, Broadridge Corporate Issuer Solutions, by telephone at (844) 998-0339. Broadridge Corporate Issuer Solutions can look up your records and make any necessary adjustments. There is a fee involved for replacing lost certificates. Information is also available at

To change the address on file for your shareholder account, you can log in to your online profile by navigating to Once on the Account Summary page, select “Address Information” from the Account Information menu.

Quarterly & Annual Reports and other investor materials, when available, can be found in the Financial Information section on the Investor Relations page of our corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at

​​​​​​You can view our recent press releases by visiting the Press Release section of our website.

For media inquiries please send an email to

​​​​​You can view information on our development programs by visiting the Pipeline section of our website.

​​​​​​For investor related questions please send an email to

Please visit the Email Alerts section of our Investor Relations site and fill out our web form to be added to the CG Oncology distribution list.

​​​​To request additional information, please visit our Contact page.